JPWO2021078835A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021078835A5 JPWO2021078835A5 JP2022523448A JP2022523448A JPWO2021078835A5 JP WO2021078835 A5 JPWO2021078835 A5 JP WO2021078835A5 JP 2022523448 A JP2022523448 A JP 2022523448A JP 2022523448 A JP2022523448 A JP 2022523448A JP WO2021078835 A5 JPWO2021078835 A5 JP WO2021078835A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- pharmaceutical composition
- composition according
- group
- filler
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2019/078905 | 2019-10-23 | ||
| EP2019078905 | 2019-10-23 | ||
| PCT/EP2020/079698 WO2021078835A1 (en) | 2019-10-23 | 2020-10-22 | Pharmaceutical composition comprising selexipag |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553313A JP2022553313A (ja) | 2022-12-22 |
| JPWO2021078835A5 true JPWO2021078835A5 (es) | 2023-10-30 |
Family
ID=75620412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523448A Pending JP2022553313A (ja) | 2019-10-23 | 2020-10-22 | セレキシパグを含む医薬組成物 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20220401441A1 (es) |
| EP (1) | EP4048235A1 (es) |
| JP (1) | JP2022553313A (es) |
| KR (1) | KR20220087443A (es) |
| CN (1) | CN114555088A (es) |
| AU (1) | AU2020369912A1 (es) |
| BR (1) | BR112022007207A2 (es) |
| CA (1) | CA3154802A1 (es) |
| EC (1) | ECSP22040921A (es) |
| IL (1) | IL292354A (es) |
| JO (1) | JOP20220093A1 (es) |
| MX (1) | MX2022004882A (es) |
| PE (1) | PE20221455A1 (es) |
| WO (1) | WO2021078835A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023195957A1 (en) * | 2022-04-05 | 2023-10-12 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | A film coated tablet comprising selexi̇pag processed with wet granulation |
| WO2023195953A1 (en) * | 2022-04-05 | 2023-10-12 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | A film coated tablet comprising selexi̇pag |
| WO2023195954A1 (en) * | 2022-04-05 | 2023-10-12 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | A film coated tablet comprising a solid dispersion of selexi̇pag |
| WO2024144679A2 (en) * | 2022-12-28 | 2024-07-04 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | A tablet formulation comprising selexi̇pag |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI316055B (es) | 2001-04-26 | 2009-10-21 | Nippon Shinyaku Co Ltd | |
| WO2009107736A1 (ja) | 2008-02-28 | 2009-09-03 | 日本新薬株式会社 | 線維化抑制剤 |
| WO2009154246A1 (ja) | 2008-06-19 | 2009-12-23 | 日本新薬株式会社 | 勃起不全治療剤 |
| JP5527206B2 (ja) | 2008-06-23 | 2014-06-18 | 日本新薬株式会社 | 炎症性腸疾患治療剤 |
| DK2292231T3 (en) | 2008-06-23 | 2015-12-14 | Nippon Shinyaku Co Ltd | THERAPEUTIC AGENT FOR SPINAL CHANNEL STENOSIS |
| WO2009157397A1 (ja) | 2008-06-23 | 2009-12-30 | 日本新薬株式会社 | 非ステロイド性抗炎症剤投与に伴う腸管傷害治療剤 |
| ES2660007T3 (es) | 2009-06-26 | 2018-03-20 | Nippon Shinyaku Co., Ltd. | Cristales |
| WO2011024874A1 (ja) | 2009-08-26 | 2011-03-03 | 日本新薬株式会社 | 塩基付加塩 |
| AU2012296953B2 (en) | 2011-08-12 | 2016-10-20 | Ascendis Pharma A/S | Sustained release composition of prostacyclin |
| US20150272874A1 (en) | 2012-10-29 | 2015-10-01 | Cardio Incorporated | Pulmonary disease-specific therapeutic agent |
| WO2017098998A1 (ja) * | 2015-12-02 | 2017-06-15 | 日本新薬株式会社 | ２－｛４－［ｎ－（５，６－ジフェニルピラジン－２－イル）－ｎ－イソプロピルアミノ］ブチルオキシ｝－ｎ－（メチルスルホニル）アセトアミドを含有する医薬組成物 |
| JOP20190204A1 (ar) * | 2017-03-08 | 2019-09-05 | Actelion Pharmaceuticals Ltd | تركيبة صيدلانية تشتمل على سيليكسيباغ |
| EP3756670A4 (en) * | 2018-02-21 | 2021-11-03 | Nippon Shinyaku Co., Ltd. | GRANULAR COMPOSITION, PROCESS FOR PRODUCING A GRANULAR COMPOSITION AND PROCESS FOR IMPROVING THE ELUTION PROPERTY OF A GRANULAR COMPOSITION |
| US20220331313A1 (en) * | 2019-05-06 | 2022-10-20 | Actelion Pharmaceuticals Ltd | Methods for treating sarcoidosis-associated pulmonary hypertension |
-
2020
- 2020-10-22 PE PE2022000625A patent/PE20221455A1/es unknown
- 2020-10-22 JO JOP/2022/0093A patent/JOP20220093A1/ar unknown
- 2020-10-22 US US17/770,155 patent/US20220401441A1/en active Pending
- 2020-10-22 KR KR1020227012736A patent/KR20220087443A/ko active Search and Examination
- 2020-10-22 EP EP20792448.1A patent/EP4048235A1/en active Pending
- 2020-10-22 AU AU2020369912A patent/AU2020369912A1/en active Pending
- 2020-10-22 WO PCT/EP2020/079698 patent/WO2021078835A1/en unknown
- 2020-10-22 IL IL292354A patent/IL292354A/en unknown
- 2020-10-22 BR BR112022007207A patent/BR112022007207A2/pt unknown
- 2020-10-22 CA CA3154802A patent/CA3154802A1/en active Pending
- 2020-10-22 MX MX2022004882A patent/MX2022004882A/es unknown
- 2020-10-22 CN CN202080071283.2A patent/CN114555088A/zh active Pending
- 2020-10-22 JP JP2022523448A patent/JP2022553313A/ja active Pending
-
2022
- 2022-05-20 EC ECSENADI202240921A patent/ECSP22040921A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6588915B2 (ja) | Ａｚｄ９２９１を含む医薬組成物 | |
| ES2935800T3 (es) | Forma de dosificación oral de ketamina | |
| JP4970452B2 (ja) | メトホルミン徐放性錠剤およびその製造方法 | |
| EP2205279B1 (en) | Pharmaceutical combination of aliskiren and valsartan | |
| KR20100129776A (ko) | 왁스를 포함하는 서방형 제형 | |
| KR20080039876A (ko) | 높은 약물 충진 제형 및 투여형 | |
| JP2020500176A (ja) | 医薬製剤 | |
| WO2015156581A1 (ko) | 안정성이 개선된 프레가발린을 함유하는 약제학적 조성물 및 이의 제조방법 | |
| US20200330433A1 (en) | Extended release pharmaceutical composition of apremilast | |
| KR20060120596A (ko) | 로피니롤의 신규 제형 | |
| JP2014501267A (ja) | メサラジン制御放出用の経口用医薬錠剤および前記錠剤を得るための製法 | |
| KR20130010044A (ko) | 콜린 알포세레이트 또는 이의 약학적으로 허용되는 염을 포함하는 서방형 약학 조성물 및 이의 제조방법 | |
| WO2010082220A2 (en) | Sustained release pharmaceutical composition of quetiapine and process for preparation thereof | |
| CA3154802A1 (en) | Pharmaceutical composition comprising selexipag | |
| GB2414668A (en) | Sustained release delivery system for tetracycline compounds | |
| KR20190015329A (ko) | 다파글리플로진 공결정의 약학 조성물 | |
| KR20070069105A (ko) | 서방성 제제 | |
| US11576917B2 (en) | Pharmaceutical compositions comprising Ibrutinib | |
| US20100172984A1 (en) | tablet dosage form comprising cetirizine and pseudoephedrine | |
| JP5211040B2 (ja) | ピリジルメチルスルフィニルベンズイミダゾールのための経口速放医薬製剤 | |
| JP2022522005A (ja) | Ｔｂｎ、又はその塩もしくは水和物を含む薬物組成物及びその製造方法 | |
| US20140010883A1 (en) | Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor | |
| US9561242B2 (en) | Doxycycline composition | |
| JPWO2021078835A5 (es) | ||
| TWI436760B (zh) | 阿利克侖之蓋崙（ｇａｌｅｎｉｃａｌ）調配物 |